United Therapeutics buy Royal Bank of Canada
Start price
26.02.26
/
50%
€426.90
Target price
26.02.27
€544.04
Performance (%)
7.99%
Price
14.07.26
€461.00
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 7.99%. This prediction currently runs until 26.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | -6.586% | -6.586% |
| iShares Core DAX® | -1.596% | 1.524% |
| iShares Nasdaq 100 | 1.432% | 1.156% |
| iShares Nikkei 225® | 1.108% | 1.735% |
| iShares S&P 500 | 0.528% | 2.967% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics (UTHR) had its price target raised by Royal Bank Of Canada from $587.00 to $643.00. They now have an "outperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€493.50
07.07.26
07.07.26
€615.51
07.07.27
07.07.27
-6.59%
14.07.26
14.07.26
United Therapeutics
Start price
Target price
Perf. (%)
€485.40
07.05.26
07.05.26
€596.27
07.05.27
07.05.27
-5.03%
14.07.26
14.07.26
United Therapeutics
Start price
Target price
Perf. (%)
€364.40
26.09.25
26.09.25
€487.63
26.09.26
26.09.26
26.51%
14.07.26
14.07.26